# Kiromic BioPharma, Inc. (KRBPQ)

> Source: Nexqual · https://nexqual.com/KRBPQ · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, Kiromic BioPharma, Inc. (KRBPQ), nexqual.com/KRBPQ" · informational, not investment advice.

**Price:** USD 0 (+0.00% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 0 · day 0.01–0.01 · 52w 0–0.01 · market cap $0K · PNK

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -98.0% vs S&P 500 +13.4%; 5Y -100.0% vs S&P 500 +76.9%.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -98.0% | -100.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -98.0% | -93.2% |
| Volatility (annualized) | 446.1% | 283.8% |
| Max drawdown | -99.8% (Oct 2025→Feb 2026) | -100.0% (Nov 2021→Feb 2026) |

## Peers (Biotechnology)
LGND (Ligand Pharmaceuticals Incorpor) USD 303.53 -1.39% · RYTM (Rhythm Pharmaceuticals, Inc.) USD 89.27 -1.79% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.09 -0.35% · PRAX (Praxis Precision Medicines, Inc) USD 252.96 -2.30% · IONS (Ionis Pharmaceuticals, Inc.) USD 42.93 -2.23% · AXSM (Axsome Therapeutics, Inc.) USD 145.04 -7.07%

## More
Full page: https://nexqual.com/KRBPQ · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2022-12-31) | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year (ends 2022-12-31) | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |